Evox Therapeutics
Evox is a pre-clinical biotech company utilising exosomes as a novel drug delivery technology platform to enable treatments for rare inherited metabolic and other diseases.
- What
- Life Sciences
- When
- Apr 2016
- CEO
- Antonin de Fougerolles
- Status
- Private
- Investment
- Active
- OSE Board Director
- Alex Hammacher